Insider Trading & Ownership - Pontifax Late Stage Fund L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Pontifax Late Stage Fund L.P.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2020-11-17
Purchase		2020-11-19
4:40 pm		Keros Therapeutics Inc.KROSNussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-11-17
Purchase		2020-11-19
4:39 pm		Keros Therapeutics Inc.KROSKariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-11-17
Purchase		2020-11-19
4:38 pm		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-04-13
Purchase		2020-04-13
5:18 pm		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		437,499$16$6,999,984149,262
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$01,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$0.00011,226,412
(Indirect)		View

Ownership(A)		2022-11-30
4:37 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		0$07,176
(Indirect)		View
2020-04-13
Conversion		2020-04-13
5:18 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		3,545,100$0149,262
(Indirect)		View

Ownership		2020-04-07
8:14 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		0$04,297,008
(Indirect)		View
(A) Indicate amendment filing.